Caremark Rx Announces Enhancements To CVS Corporation Merger

Published: Mar 09, 2007

NASHVILLE, Tenn.--(BUSINESS WIRE)--Caremark Rx, Inc. (NYSE: CMX) today announced that the value of its pending merger with CVS Corporation (NYSE: CVS) has been enhanced by an increased special cash dividend of $7.50 per share, up from $6.00 per share, payable to Caremark shareholders promptly following closing. The total value of the special cash dividend is now approximately $3.2 billion.

Back to news